Drug data last refreshed 13h ago · AI intelligence enriched 3w ago
TECHNESCAN HIDA is a radiopharmaceutical diagnostic agent containing technetium Tc-99m lidofenin, used for hepatobiliary imaging to assess liver function and biliary tract patency. It is a kit-based injectable product that requires radiolabeling with technetium Tc-99m at the point of use. The drug enables visualization of hepatic uptake and excretion through gamma camera imaging.
With LOE approaching and moderate competitive pressure (30%), commercial teams are likely focused on lifecycle management and defending market position rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on TECHNESCAN HIDA offers limited career expansion given its LOE-approaching status and zero linked job openings; roles focus on lifecycle management and market defense rather than growth initiatives. This assignment is best suited for professionals seeking operational stability or transition roles within a mature therapeutic area.
Worked on TECHNESCAN HIDA at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.